The authors examined physician diagnostic certainty as one reason for cross-national medical practice variation. Data are from a factorial experiment conducted in the United States, the United Kingdom, and Germany, estimating 384 generalist physicians' diagnostic and treatment decisions for videotaped vignettes of actor patients depicting a presentation consistent with coronary heart disease (CHD). Despite identical vignette presentations, the authors observed significant differences across health care systems, with US physicians being the most certain and German physicians the least certain (P < 0.0001). Physicians were least certain of a CHD diagnoses when patients were younger and female (P < 0.0086), and there was additional variation by health care system (as represented by country) depending on patient age (P < 0.0100) and race (P < 0.0021). Certainty was positively correlated with several clinical actions, including test ordering, prescriptions, referrals to specialists, and time to follow-up.
The authors examined physician diagnostic certainty as one reason for cross-national medical practice variation. Data are from a factorial experiment conducted in the United States, the United Kingdom, and Germany, estimating 384 generalist physicians' diagnostic and treatment decisions for videotaped vignettes of actor patients depicting a presentation consistent with coronary heart disease (CHD). Despite identical vignette presentations, the authors observed significant differences across health care systems, with US physicians being the most certain and German physicians the least certain (P < 0.0001). Physicians were least certain of a CHD diagnoses when patients were younger and female (P < 0.0086), and there was additional variation by health care system (as represented by country) depending on patient age (P < 0.0100) and race (P < 0.0021). Certainty was positively correlated with several clinical actions, including test ordering, prescriptions, referrals to specialists, and time to follow-up. Key words: clinical decision making; medical practice variation; health disparities. (Med Decis Making 2009; 29:606-618) V ariations in the provision of health care and associated health disparities are a topic of longstanding concern for policy makers, clinical providers, and health researchers alike. Although differences in clinical decision making (CDM) have been observed for many conditions, 1 coronary heart disease has received particular attention and has been shown repeatedly to result in differential diagnostic and treatment decisions by physicians. 2, 3 Differences have been observed in the use of coronary revascularization services, 4 hospitalization for hypertension, 5 history taking, 6 and gender differences in attributions of cardiac-related symptoms. 7 These variations in medical practice occur as a function of patient characteristics such as race, 4, 5 age, 5, 7, 8 socioeconomic status, [9] [10] [11] gender, [12] [13] [14] and comorbidity status, 15 as well as provider and system attributes such as gender, 16 attitudes toward aging, 17 perceptions of pressure from patients, 18 and practice culture. 19 Studies of the United States, including especially the RAND Health Services Utilization Study 20 and the Dartmouth Atlas of Health Care 21, 22 project, have consistently documented geographic variations in health care and have worked over the past 2 decades to understand why it occurs. Similar differences have been observed cross-nationally among the United States, France, and England 23 ; between the United States and Canada 24 and the United States and United Kingdom 25 ; among Eastern European countries 26 ; and in the SYMPHONY trial, a study of 37 countries. 27 How physicians process complex and varied sources of information has been a topic of interest for decades. Classic studies underscore the importance of threshold models for conceptualizing the triggers that prompt physicians to do further testing and, if warranted, provide treatment. 28, 29 More recently, related literature in social psychology and economics examines how physicians' cognitive processing-particularly prejudice, stereotyping, discrimination, and uncertainty-may bias their assessments of patients and decisions about their treatment. [30] [31] [32] Low health literacy also contributes to difficulties in chronic illness management, and such challenges to doctor-patient communication may exacerbate physician uncertainty. 33, 34 This literature, which is quite focused on providing microlevel explanations for observed variation, is often not equipped to also provide information about cross-national differences.
We build on these 2 literatures by examining how physicians' diagnostic certainty functions in clinical decision making for coronary heart disease (CHD). Using cross-national experiment data, we are able to simultaneously 1) address the role of diagnostic certainty in observed variations and 2) estimate relative contributions of patient, provider, and health care system influences on clinical decision making.
From a Bayesian decision theory perspective, these variations in clinical decision making should be determined in part by the prevalence of the relevant condition in the larger population. In crossnational studies, for example, women have slightly higher prevalence of angina relative to men (despite higher mortality rates among men), a difference that should influence individual clinical decisions. [35] [36] [37] Research on the socially constructed aspects of health statistics, however, suggests that biases in clinical decision making and medical treatment contribute independently to differences in some types of health statistics. 38 Additional work has shown women have poorer outcomes after acute myocardial infarction 39 and in cardiovascular and diabetes care, 13, 14 both after adjusting for covariates. From this perspective, differences in rates may not only reflect epidemiologic differences in underlying disease but also cumulative interactions between patients and physicians.
Using data from a video vignette experiment, we examine the magnitude and sources of variation in CDM for identical presentations of CHD in 3 different health care systems: 1) the free market medical system in the United States, 2) the governmentbased National Health Service of the United Kingdom, 40 and 3) the nonprofit insurer-based system used in Germany. 41 This work expands existing social psychological research on CDM to include cross-national comparisons, as well as providing specific evidence for how uncertainty operates in CDM. Building on earlier work showing physicians in different countries had comparable rates of correct diagnoses, we find that diagnostic certainty has independent and unique effects on clinical decision making. 25 We address the following research questions: 1) How certain were physicians of their diagnoses of CHD, and how did that vary by health care system? 2) Which types of physicians were the most certain? 3) Which types of patients elicited the highest certainty levels among physicians? 4) How did these patient and provider effects vary across 3 countries? 5) How was diagnostic certainty associated with subsequent patient management, such as information seeking, test ordering, prescribing, lifestyle recommendations, and referrals/follow-up?
DATA AND METHODS
We conducted a factorial experiment to simultaneously measure the effects of 1) patient attributes (age, gender, race, and socioeconomic status), 2) physician characteristics (gender and years of clinical experience), and 3) separate health care systems (the United States, United Kingdom, or Germany) on physician diagnostic certainty and subsequent medical decision making when providers are presented with identical signs and symptoms indicative of CHD. Experiments were conducted in the United States (Massachusetts), United Kingdom (the West Midlands, Southeast London, and Surrey), and Germany (Northern Rhine/Westfalia region). 42 A full factorial of combinations of patient age (55 years v. 75 years), gender, race (white v. black in the United States, white v. Afro-Caribbean in the United Kingdom, and white only in Germany), and socioeconomic status (SES; lower v. higher social class, depicted by occupation as a cleaner/janitor v. a teacher) was used for the videotaped vignette scenarios (2 4 = 16 unique vignettes). The decision to omit the race factor from the German experiment was based on discussions with our German colleagues, who advised us that the physicians in our sampling area saw few black patients in their everyday practices. Audios for the vignettes were dubbed into German and backtranslated to ensure accuracy. One of the 16 combinations was shown to each physician. CHD was selected for the vignettes because 1) it is among the most common and costly problems presented by older patients to primary care providers 43 ; 2) it represents a clinically well-defined medical condition; 3) it admits a range of diagnostic, therapeutic, and lifestyle actions; and 4) its reported prevalence differs among the United States, United Kingdom, and Germany. Scripts for the vignettes were developed from several tape-recorded role-playing sessions with experienced clinical advisers, and professional actors were trained (under experienced physician supervision) to realistically portray a patient presenting with the signs/symptoms of disease to a primary care provider. Patients in the vignette presented with signs and symptoms that were consistent with CHD, including chest pain worsening with exertion, pain in the back between the shoulder blades, stress, and elevated blood pressure. All patients included a nonverbal ''Levine's fist,'' a well-known gesture indicative of cardiac pain. Because CHD is a spectrum condition, and live patients do not typically present as clear-cut textbook cases of specific conditions, the vignette also built in several red herring symptoms potentially indicative of a gastrointestinal diagnosis. To this end, the patient also complained of indigestion, feeling worse after a large or spicy meal, having pain similar to heartburn but unresponsive to antacids, and feeling full and ''gassy.'' This was done not to specifically make the physicians' diagnostic task more difficult but to more accurately represent how actual patients present, based on advice from our clinical advisers. The vignette also incorporated references to the patient's mood, including the spouse's report that the patient has been difficult to be around and the patient's self-report of feeling irritated and having decreased energy (see the appendix for an illustrative excerpt from the vignette).
After viewing the videotaped vignette, physicians were asked, ''What do you think is going on with this patient?'' and for each possibility, they were asked for their level of certainty on a scale of 0 to 100 (where 0 = no certainty and 100 = complete certainty). Physicians were asked through an open-ended question from the interviewer to list their full set of differential diagnoses, and if CHD was present anywhere on that list, they were counted as having considered the condition, and the accompanying certainty level was included in the present analysis. Physicians were also asked how they would manage the patient in terms of asking for additional information, performing physical examinations, ordering tests, prescribing medications, giving lifestyle advice, and referring to other physicians.
On the basis of the theoretical approach outlined above and our concerns about the social construction of epidemiologic base rates, we do not appeal to population rates of disease to ascertain the ''correctness'' of a given diagnosis. Rather, we assume that although a physician's diagnostic priors (among many other sources of learning) may inform decision making, patient-specific clinical information should be used above and beyond those preexisting base rates. Therefore, the vignette for this study was purposely designed to present a set of signs and symptoms sufficient to trigger a CHD diagnosis, regardless of the epidemiologic prevalence in any subgroup of the population. In this sense, the vignette provides sufficient information to suspect the condition, regardless of the social characteristics of the patient.
The study used a probability sample of physicians selected from within each of 4 strata within each country. To be eligible for selection, physicians had to 1) be internists or family practitioners in the United States and in Germany or general practitioners in the United Kingdom (to most accurately capture the types of nonspecialist physicians most likely to treat undiagnosed cases of CHD in each country), 2) be trained at an accredited medical school in the country in which they practiced (no international medical graduates were included), and 3) be currently in clinical practice more than halftime. Within each country, physicians were stratified into 4 equal cells by gender and level of experience, with ''less'' experience defined as those with ≤ 12 years since graduation from medical school in the United States or United Kingdom ( ≤ 7 years since licensure in Germany) and those with ''more'' experience having ≥ 22 years since graduation from medical school in the United States or United Kingdom ( ≥ 17 years since licensure in Germany). These cutoff dates were chosen to act as a proxy for clinical experience (which has been shown to affect clinical decision making, as discussed above), to standardize as much as possible the amounts of clinical experience across countries, and to create a clear separation between the strata. Twelve strata of physician characteristics (gender, years of clinical experience [< 12 or > 22 years], and health care system [United States/United Kingdom/Germany]) were defined, with 32 physicians included in each stratum from each country. This configuration generated a total of 384 physicians required to complete the design and the experiment (16 vignettes × 12 physician strata × 2 replications = 384; Table 1 ).
Screening telephone calls were conducted to identify eligible participants, and an hour-long appointment was scheduled for the interviewer to [Germany]) and to acknowledge his or her participation. Quality control interviews and site visits were conducted, and selected tape-recorded interviews were reviewed by supervisors on a regular basis.
Analysis of variance was used to test the main effects and 2-way interactions of the design variables (patient gender, race, age, SES, and physician gender and level of experience) on the diagnostic certainty (0-100, with 0 for not at all certain and 100 for completely certain). If the physician did not make a CHD diagnosis, his or her certainty for these diagnoses was set to 0. To determine the effect of certainty on clinical decision making, we used logistic regression for dichotomous variables (e.g., whether or not an electrocardiogram [EKG] was ordered), and analysis of covariance was used for continuous variables (e.g., number of days to next appointment). Each model included as explanatory variables the design variables, certainty, and the interaction of the design variables and certainty. Using backward elimination, nonsignificant effects (at the 0.05 level) other than certainty were removed from the model, leaving a parsimonious model. Because of the challenges of multiple testing, we emphasize consistency across results and focus on identifying general patterns of physician certainty and treatment decisions.
Furthermore, the results we observe at the P < 0.01 level are unlikely to change. To facilitate interpretation, we present actual P values, unadjusted for multiple testing. To further facilitate interpretation of results, we indicate in Tables 2 to 4 the number of expected and observed significant results.
RESULTS

How Certain Were Physicians and How Did That Vary by Practice Setting (Country)?
Across all 3 countries, the vast majority of physicians correctly considered CHD (74.2% in Germany, 88.3% in the United Kingdom, 95.3% in the United States, and 85.9% overall, P < 0.0001), yet there were also significant differences in how many physicians failed to consider CHD in each health care system, with a 21.1% difference in rates between Germany and the United States.
Physicians' certainty levels for CHD diagnosis varied from 0 to 100, with an average of 52.1 (see Figure 1 ). Again, there was significant variation across countries, with the US physicians having the highest average certainty (57.9), followed by the United Kingdom (46.4) and Germany (38.9; P < 0.0001; Table 2 ). Using Tukey's method of multiple comparisons, we found that the level of certainty in the United States was significantly higher than that in either the United Kingdom or Germany, whereas the certainty levels were statistically comparable in the United Kingdom and Germany.
Which Physicians Were the Most Certain?
We next examined whether physician characteristics (gender and years of experience) were associated with certainty, independent of the health care system in which providers practiced ( Table 2) . Although there were no significant main effects for physician characteristics, we did observe an interaction between patient race and physician level of experience ( Figure  2a ). With white patients, physicians had comparable certainty levels (54.1 v. 53.0, less and more experienced, respectively). With black patients, however, more experienced physicians had increased certainty (56.9), whereas those with less experience were less certain (44.5).
With Which Patients Were Physicians Most Certain?
Independent of health care system differences, physician certainty varied significantly according to the gender of the patient, with physicians reporting higher average certainty levels with male v. female patients (51.8 v. 43.7, P = 0.0058) and by age, with higher certainty for older patients (53.1 v. 42.4, P = 0.0003). We also observed an interaction between patient age and gender, such that physicians were much less certain in making a CHD diagnosis for younger women (34.5) with otherwise identical symptom presentation (P = 0.0086; Figure  2b ). There were no main effects of patient race or SES on certainty ( Table 2) .
How Did Patient and Provider Effects Vary Across Countries?
In addition to the main effect differences between countries, we also observed variation between countries according to characteristics of the presenting patient (Table 2) . First, we observed an interaction between patient age and health care system, with US physicians having comparable diagnostic certainty for younger (55- Figure 2c ). Second, there was an interaction between health care system and patient race. Although physicians in the United States and United Kingdom had similar certainty levels for black patients (51.2 v. 50.3), their certainty levels diverged when the patient was white, with US physicians having increased certainty and UK physicians being less certain (42.5 v. 64.7, P = 0.0015; Figure 2d ).
What Was the Effect of Certainty on Clinical Decision Making?
In turn, physicians' diagnostic certainty for CHD significantly influenced their subsequent diagnostic and therapeutic clinical actions (Tables 3 and 4 ). Logistic regression results showed that for each 10point increase in certainty for a CHD diagnosis, physicians were less likely to ask questions about the patient's psychological state (odds ratio [OR] = 0.91, P = 0.0163) or social environment (OR = 0.88, P = 0.0062), but they were more likely to ask about other general information (OR = 1.10, P = 0.0232; Table 4 ). We also observed an interaction of patient SES and certainty on the odds of asking questions about smoking. As the certainty of the CHD diagnosis increased, physicians were more likely to ask lower SES patients about smoking (OR = 1.14, P = 0.0065), but certainty had no effect on the likelihood of physicians asking upper SES patients about smoking. Certainty was also significant for test ordering behavior. For example, as certainty of a CHD diagnosis increased, physicians from the United States and United Kingdom were significantly more likely to order at least one diagnostic test for CHD (P < 0.0001), whereas this relationship did not hold for German physicians (Table 4 ). Furthermore, as certainty increased, UK and US physicians ordered greater numbers of CHD-related tests (P < 0.0001), whereas certainty did not significantly affect the number of CHD-related tests that the German physicians ordered (Table 3) . However, increased certainty was associated with increased likelihood of physicians from all 3 countries ordering stress tests and EKG tests (P < 0.0001), and this effect was the strongest in the United States (OR = 1.95, P < 0.0001; Table 4 ). Increased certainty was associated with higher odds of writing a CHD-appropriate prescription (beta-blockers, calcium channel blockers, aspirin, and short-acting nitrates; OR = 1.53, P < 0.0001) in all 3 countries. Higher certainty of a CHD diagnosis also increased the odds of a physician referring the patient to a cardiologist (OR = 1.23, P < 0.0001). Finally, increased certainty was significant for predicting how soon a physician would request to see the patient again (P = 0.0003), with a repeat visit requested 0.44 days sooner per 10-point increase in certainty.
DISCUSSION
We observed significant differences between health care systems, with US physicians having the highest levels of certainty. As expected, physicians were least certain of their CHD diagnoses with younger female patients. 12, 44 In addition, there was racial variation depending on the physician's level of experience and variation by health care system depending on patient age and race. Increased certainty was associated with differences in information seeking as well as increased test ordering, prescriptions, referrals to cardiologists, and shorter time to follow-up.
Previous studies of medical practice variation have largely focused on either system-level social and economic patterns in CDM or on physicians' individual-level cognitive processing as mechanisms that may generate such variation. The factorial design of our experiment allowed for unconfounded estimates of the simultaneous effects of patient characteristics, provider attributes, and health care systems (as represented by country) on physicians' certainty of CHD diagnoses and their subsequent clinical actions. With our analytic approach, we were able to capture physicians at all points on the certainty spectrum rather than excluding those who did not list CHD among their differential diagnosis selections. Although those who did not consider CHD among their differential diagnosis selections did not provide an explicit certainty value, we know their certainty concerning the presence of CHD was low because they were allowed to list a full set of diagnoses (we recognize that physicians may have high certainty that CHD is absent from the vignette, but this is beyond the scope of the present analysis). Therefore, if they were treated as missing, they would not be missing at random. By increasing the variability, our estimates are rendered more conservative because of a decrease in power.
The sample size of 384 allows us to detect a difference in certainty of 12 points with 97% power, assuming a standard deviation of 30 (which, assuming a unimodal beta distribution of 0-1, is the upper bound of a standard deviation). That is, a true 12point difference in certainty between 2 groups will be detected 97% of the time at a = 0.05. Because the experiment was replicated, a pure error term with 192 degrees of freedom was used to test all effects using analysis of variance. because of the omission of the race factor for the German experiment (explained above), only the US and UK data are considered for the effect of patient race on certainty. For all other analyses, all data were considered.
The main effects related to patient characteristics (decreased certainty with female and younger patients) partially corroborate Bayesian perspectives and studies of uncertainty and statistical discrimination, 31, 45 suggesting that when physicians are uncertain, they are likely to make diagnostic decisions that are consistent with existing epidemiologic base rates. In this case, prior assumptions overwhelm the presenting patient-specific data, thereby contributing to the reification of some types of existing health statistics. Most important, these findings extend previous work by showing that certainty-not simply identifying a diagnosis but having diagnostic certainty about that conditionhas an independent effect on clinical actions. 46 Therefore, these results suggest that having CHD on the differential diagnosis list is necessary but not sufficient for physicians to take appropriate therapeutic actions; this result is consistent with the notion that physicians need to pass certainty thresholds to order more tests or treat a patient. 28 By extension, improving disparities in CHD outcomes is not just a matter of physicians learning to consider CHD more appropriately in specific populations (e.g., women) but also to be able to do so with sufficient certainty to trigger appropriate clinical actions to improve morbidity and mortality outcomes. However, these perspectives do not fully explain our results, and the persistence of some betweenhealth care system differences implies that features of the broader sociological, cultural, and organizational environments are also relevant to decision making. Beyond diagnostic certainty, observed cross-national variation in CHD diagnosis and treatment may also be a function of differences in a series of influences that are beyond the scope of the present analysis or our study more generally. These include both patients' and physicians' cultural expectations for medical practice and treatment as well as biological variations in the prevalence of CHD and related conditions at a population level, such that physicians in different health care systems may be differentially equipped to identify CHD with certainty. For example, previous research has shown cross-cultural differences in the relationship between symptoms and underlying conditions. 47, 48 Other possible explanations include funding mechanisms, expectations for physicians to achieve diagnostic certainty in a brief period of time, modes of practice, and access to resources across the 3 countries. For example, economic reimbursement policies may translate to more pressure on US physicians to achieve a firm diagnosis and management plan during the initial patient consultation so they can be paid, whereas in the United Kingdom and Germany, physicians may tend to make these decisions over a series of consultations close together in time. Similarly, ready availability of technological equipment in Massachusetts in conjunction with a fear of lawsuits for missed diagnoses may lead to increased testing in the United States relative to physicians in the United Kingdom or Germany, whereas increased rates of referral among UK and German physicians 25 may explain lower rates of testing and prescription treatment relative to the United States. Increased regulation in the United Kingdom with pay-for-performance may also contribute to the UK physicians' higher certainty relative to their German counterparts, where professional pressures and regulations are not yet as explicit as in the United States. 49 Most generally, physician learning is known to be related to the local context of practice, such that physicians may either self-select into environments with practice styles similar to their own or adapt to the local culture-either type of pattern could exist within the local contexts that were selected from each country for this study.
Every study represents a balance between internal and external validity. We recognize that our vignette-based approach has some limitations compared to studies of behavior in natural interactionthe most obvious being that physicians do not directly interact with the patient in the vignette. For present purposes, vignettes offer several key advantages over alternative methods: they 1) allow for the manipulation of several variables at once and the measurement of unconfounded effects, thereby ''isolating physicians' decision making from other factors in the environment'' 50 ; 2) provide a standardization of case mix; 3) allow vignette-based studies to collect a large amount of information simultaneously from a large number of subjects; 4) make efficient use of time; and 5) are cost-effective (e.g., standardized patients would have been prohibitively expensive in this context). In a direct comparison of vignettes, standardized patients, and chart abstraction, Peabody and colleagues 51 validated the use of vignettes for studying quality of outpatient care, and studies comparing vignettes with standardized patients and other methods corroborate the result that vignettes are ecologically valid for studies of medical decision making. 50, 52, 53 We took 4 precautionary steps in an attempt to minimize possible threats to external validity and compensate for the artificial aspects of the experimental situation (i.e., that physicians may behave differently with a videotaped patient under experimental conditions compared with real patients in an everyday clinical setting). First, considerable effort was devoted to ensuring the clinical authenticity of the videotaped presentation. Expert clinical consultants were actively involved in all stages of the process, from early stages of role-playing and script development to final stages of film shooting, where they oversaw vignette filming to determine face and content validity. Second, the doctors viewed the tapes in the context of their practice day (often during their lunch periods) to maximize the likelihood that they encountered real patients before and after they viewed the patient in the videotape and also so they were in a physical setting they associated with decision making. Third, the doctors were specifically instructed at the outset to view the patient as one of their own patients and to respond as they would typically respond in their own practice. In the United States, 90.6% of the doctors considered the vignettes to be very or reasonably typical, with 91.4% in the United Kingdom and 81.3% in Germany.
Our study has limitations that underscore the need for additional research. First, questions remain about how physicians cognitively process these cues from patients. Previous research in cognitive psychology has suggested that physicians often rely on pattern recognition as well as more analytic types of processing, such as Bayesian decision making, when evaluating patient cues. 54, 55 However, these questions are beyond the scope of the present study, and these data do not allow us to specify the exact cognitive and psychological processes physicians use when interpreting information from the vignettes. A similar study of US physicians (with the same CHD vignette) primed physicians to determine whether the underdiagnosis of CHD in some patient populations was due to physicians not considering that diagnosis or considering it and then eliminating it from their differential diagnosis. 56 Also beyond the scope of this study, but potentially related, is the question of differences in clinical decision-making practices between family practitioners and internists, despite both groups being likely to treat the type of patient depicted in the vignette.
Although the cross-national component of our study identified persistent differences between countries, there remains limited generalizability from each group of physicians to the entire population of physicians in their respective countries. In terms of statistical and clinical significance, our results are relatively modest and therefore limited in their ability to explain the wide range of crossnational variations that have been identified in existing literature. However, the possible explanations outlined above build on our current results and are promising avenues for future inquiry.
In summary, our findings underscore the role of uncertainty during the clinical decision-making process in contributing to or amplifying CHD-related disparities. To the extent that inequalities are generated from within health care systems, researchers and policy makers should continue to develop interventions targeted at the level of the patient-physician encounter while also considering which broader, system-level factors influence individual physician behaviors. Because diagnostic certainty is so important for understanding subsequent clinical actions, our results also highlight the need for interventions to not only increase diagnostic accuracy but also increase certainty to lead to optimal therapeutic actions. 
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